| Evaluation of the TCR Repertoire as a Predictive and Prognostic Biomarker in Cancer: Diversity or Clonality? A Aran, L Garrigós, G Curigliano, J Cortés, M Martí Cancers 14 (7), 1771, 2022 | 20 | 2022 |
| Analysis of tumor infiltrating CD4+ and CD8+ CDR3 sequences reveals shared features putatively associated to the anti-tumor immune response A Aran, G Lázaro, V Marco, E Molina, F Abancó, V Peg, M Gión, ... Frontiers in Immunology 14, 1227766, 2023 | 2 | 2023 |
| Epstein–Barr Virus+ B Cells in Breast Cancer Immune Response: A Case Report A Aran, V Peg, RM Rabanal, C Bernadó, E Zamora, E Molina, YA Arribas, ... Frontiers in Immunology. 2021; 12: 761798 12, 2021 | 2 | 2021 |
| Protein-only Nanoparticles for T Cell Expansion and Activation M Fornt-Suñé, GL Bermejo, M Gil-Garcia, A Aran, J Garcia-Pardo, M Martí, ... ACS Applied Nano Materials, 2024 | | 2024 |
| Peptide repertoire of EBV+ tumor infiltrating B cells from a triple negative breast cancer patient A Aran, Y Arribas, C Bernadó, J Arribas, E Zamora, J Cortés, M Carrascal, ... Molecular Immunology 150, 25-26, 2022 | | 2022 |
| Caracterización de los linfocitos infiltrantes de tumor desde la perspectiva del TCR y la presentación antigénica en el cáncer de mama A Aran | | 2022 |
| Comparative analysis and characterization of TCR repertoires in breast cancer TILs A Aran, E Molina, F Abanco, V Marco Molina, J Perez, J Cortes, M Marti EUROPEAN JOURNAL OF IMMUNOLOGY 51, 313-313, 2021 | | 2021 |
